Sun Protection Factor Assay (SPF Assay 202/2016)
To evaluate the Sun Protection Factor efficacy on human skin.
- Fitzpatrick Skin Type l, ll and/or lll for UVB testing. Fitzpatrick Skin Type ll, lll and/or lV for UVA testing. - Male and female. - Aged between 18-70 years old. - Good health as determined from the HRL SHF (Subject History Form). - Signed and dated Informed Consent Form. - Signed and dated HIPAA (Health Insurance Portability and Accountability Act) form. - An unambiguous MED (Minimal Erythema Dose) or MPPD (Minimal Persistent Pigment Darkening Dose).
- Subjects on test at any other research laboratory or clinic. - Known allergy or sensitivity to sunscreens, cosmetics and toiletries, topical drugs and/or ultraviolet light. - Pre-existing dermatologic conditions which have been diagnoses by a medical professional (e.g. psoriasis, eczema, etc.) which would interfere with this study. - Pre-existing other medical conditions (e.g. adult asthma, diabetes). - Treatment with antihistamines or corticosteroids within one week prior to initiation of the test. - Treatment with antibiotics within two weeks prior to initiation of the test. - Chronic medication which could affect the results of the study. - Known pregnant or nursing women.
Union, United States, 07083
E-mail: [email protected]
Phone: Not Available
Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose
Single Group Assignment